# Panacea Biotec (NSE: PANACEABIO) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/PANACEABIO · Pivot · prices to 22 Oct 2026

Panacea Biotec (NSE: PANACEABIO) closed at ₹335.85 on 22 Oct 2026, down 1.22% on the day. With a market capitalisation of ₹2,057 Cr, it ranks 1133rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Biotechnology.

Its return on equity was −1.0% in FY25. Over the past year the share price has fallen 24.2%. Its 52-week range is ₹292.40 (30 Mar 2026) to ₹647.00 (9 Jun 2026); the last close is 48.1% below the high. Promoters held 72.48% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹335.85 |
| Market cap | ₹2,057 Cr |
| ROE | −1.0% (FY25) |
| ROCE | −4.3% (FY25) |
| Debt to equity | 0.02 |
| 52-week high | ₹647.00 (9 Jun 2026) |
| 52-week low | ₹292.40 (30 Mar 2026) |
| 1-year return | −24.2% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹559 Cr | −₹9 Cr |
| FY24 | ₹559 Cr | −₹2 Cr |
| FY23 | ₹460 Cr | −₹34 Cr |
| FY22 | ₹661 Cr | ₹1,078 Cr |
| FY21 | ₹625 Cr | −₹148 Cr |
| FY20 | ₹544 Cr | −₹195 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 72.48%
- Foreign institutions: 2.31%
- Domestic institutions: 2.25%
- Non-institutions: 22.96%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Medi Assist Healthcare Services](https://app.pivotnow.in/stock/MEDIASSIST) | ₹291.75 | ₹2,179 Cr | 24.1 | — |
| [Syncom Formulations (India)](https://app.pivotnow.in/stock/SYNCOMF) | ₹22.83 | ₹2,146 Cr | 28.2 | — |
| [Indoco Remedies](https://app.pivotnow.in/stock/INDOCO) | ₹230.55 | ₹2,128 Cr | — | — |
| [Sakar Healthcare](https://app.pivotnow.in/stock/SAKAR) | ₹923.90 | ₹2,056 Cr | 67.6 | — |
| [Sai Parenterals](https://app.pivotnow.in/stock/SAIPARENT) | ₹461.90 | ₹2,041 Cr | 103.6 | — |
| [Beta Drugs](https://app.pivotnow.in/stock/BETA) | ₹1,773.00 | ₹1,966 Cr | 43.4 | — |

## Questions and answers

### What is the share price of Panacea Biotec today?

Panacea Biotec (NSE: PANACEABIO) last closed at ₹335.85 on 22 Oct 2026. Its 52-week high is ₹647.00 and its 52-week low is ₹292.40.

### What is the market cap of Panacea Biotec?

Panacea Biotec's market capitalisation is ₹2,057 Cr (₹2,057 Cr) at the 22 Oct 2026 close, ranking 1133rd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Panacea Biotec?

Return on equity was −1.0% in FY25 and return on capital employed was −4.3% in FY25 (consolidated figures).

### Is Panacea Biotec a debt-free company?

Panacea Biotec is close to debt-free: its debt-to-equity ratio was 0.02 in FY25.

### How has Panacea Biotec stock performed over the last year?

Panacea Biotec's share price has fallen 24.2% over the past year, −27.3% over three months and −10.7% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Panacea Biotec?

As of 30 Jun 2026: promoters 72.48%, foreign institutions 2.31%, domestic institutions 2.25%, non-institutions 22.96%.

### Who are Panacea Biotec's competitors?

The listed Pharma & Healthcare companies closest to Panacea Biotec by market cap are Medi Assist Healthcare Services, Syncom Formulations (India), Indoco Remedies, Sakar Healthcare, Sai Parenterals and Beta Drugs.

### Is Panacea Biotec a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Panacea Biotec's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on PANACEABIO against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.